Professor Matti Lehtinen of the Karolinska Institutet (Stockholm, Sweden) and the Finnish Institute for Health and Welfare (Helsinki, Finland) visited the International Agency for Research on Cancer (IARC) on 3 March 2020 and presented a seminar on “Population-based trials on the safety, immunogenicity, efficacy and impact of human papillomavirus (HPV) vaccination.” HPV causes, among other diseases, cancers of the cervix and oropharynx. A Swedish–Finnish study shows that the most oncogenic HPV types can be eradicated, but only if both girls and boys are vaccinated. As of 2020, both girls and boys in Sweden are offered HPV vaccination.
Dr Matti Lehtinen
|